(-)-epigallocatechin 3-gallate multiple interactions ISO REV3L (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of REV3L mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression ISO Rev3l (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of REV3L mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Rev3l (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of REV3L mRNA] CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO Rev3l (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of REV3L mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO REV3L (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of REV3L mRNA CTD PMID:20660070 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Rev3l (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of REV3L mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of REV3L mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of REV3L mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO REV3L (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of REV3L mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Rev3l (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of REV3L mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of REV3L mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO REV3L (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REV3L mRNA CTD PMID:28628672 4-hydroxynon-2-enal multiple interactions ISO Rev3l (Mus musculus) 6480464 REV3L protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] CTD PMID:22331492 4-hydroxynon-2-enal affects response to substance ISO Rev3l (Mus musculus) 6480464 REV3L protein affects the susceptibility to 4-hydroxy-2-nonenal CTD PMID:22331492 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of REV3L mRNA CTD PMID:30047161 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of REV3L mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO Rev3l (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of REV3L mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO REV3L (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of REV3L gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO Rev3l (Mus musculus) 6480464 Tretinoin results in increased expression of REV3L mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO REV3L (Homo sapiens) 6480464 Tretinoin results in decreased expression of REV3L mRNA CTD PMID:15498508 all-trans-retinoic acid increases expression ISO REV3L (Homo sapiens) 6480464 Tretinoin results in increased expression of REV3L mRNA CTD PMID:21934132 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of REV3L mRNA CTD PMID:30047161 aristolochic acid A decreases expression ISO REV3L (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of REV3L mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO REV3L (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to REV3L mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO REV3L (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of REV3L mRNA CTD PMID:20106945 benzo[a]pyrene increases methylation ISO Rev3l (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of REV3L exon and Benzo(a)pyrene results in increased methylation of REV3L intron CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Rev3l (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of REV3L mRNA CTD PMID:15034205 benzo[a]pyrene multiple interactions ISO Rev3l (Mus musculus) 6480464 AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of REV3L mRNA] CTD PMID:15034205 benzo[a]pyrene increases expression ISO Rev3l (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of REV3L mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I multiple interactions ISO Rev3l (Mus musculus) 6480464 REV3L protein affects the reaction [7 more ... CTD PMID:22331492 benzo[a]pyrene diol epoxide I affects response to substance ISO Rev3l (Mus musculus) 6480464 REV3L protein affects the susceptibility to 7 more ... CTD PMID:22331492 benzo[a]pyrene diol epoxide I decreases expression ISO REV3L (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 bis(2-chloroethyl) sulfide decreases expression ISO Rev3l (Mus musculus) 6480464 Mustard Gas results in decreased expression of REV3L mRNA CTD PMID:19778212 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of REV3L mRNA CTD PMID:25181051 bisphenol A increases expression ISO Rev3l (Mus musculus) 6480464 bisphenol A results in increased expression of REV3L mRNA CTD PMID:35598803 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of REV3L mRNA CTD PMID:32145629 bisphenol A increases expression ISO REV3L (Homo sapiens) 6480464 bisphenol A results in increased expression of REV3L mRNA CTD PMID:29275510 and PMID:33670352 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of REV3L mRNA CTD PMID:30816183 bisphenol A multiple interactions ISO REV3L (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REV3L mRNA CTD PMID:28628672 cadmium atom multiple interactions ISO REV3L (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of REV3L mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO REV3L (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of REV3L mRNA CTD PMID:35301059 carbamazepine affects expression ISO REV3L (Homo sapiens) 6480464 Carbamazepine affects the expression of REV3L mRNA CTD PMID:24752500 cisplatin decreases response to substance ISO Rev3l (Mus musculus) 6480464 REV3L protein results in decreased susceptibility to Cisplatin CTD PMID:21068376 clobetasol decreases expression ISO Rev3l (Mus musculus) 6480464 Clobetasol results in decreased expression of REV3L mRNA CTD PMID:27462272 clorgyline increases expression ISO REV3L (Homo sapiens) 6480464 Clorgyline results in increased expression of REV3L mRNA CTD PMID:19691856 copper atom increases expression EXP 6480464 Copper results in increased expression of REV3L mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of REV3L mRNA CTD PMID:30556269 curcumin increases expression ISO REV3L (Homo sapiens) 6480464 Curcumin results in increased expression of REV3L protein CTD PMID:19137819 cyclosporin A decreases expression ISO REV3L (Homo sapiens) 6480464 Cyclosporine results in decreased expression of REV3L mRNA CTD PMID:25562108 dexamethasone increases expression ISO REV3L (Homo sapiens) 6480464 Dexamethasone results in increased expression of REV3L mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO REV3L (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REV3L mRNA CTD PMID:28628672 diazinon increases methylation ISO REV3L (Homo sapiens) 6480464 Diazinon results in increased methylation of REV3L gene CTD PMID:22964155 diclofenac affects expression ISO REV3L (Homo sapiens) 6480464 Diclofenac affects the expression of REV3L mRNA CTD PMID:24752500 dorsomorphin multiple interactions ISO REV3L (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO REV3L (Homo sapiens) 6480464 REV3L protein affects the susceptibility to Doxorubicin CTD PMID:16217747 ethyl methanesulfonate increases expression ISO REV3L (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of REV3L mRNA CTD PMID:23649840 folic acid multiple interactions ISO Rev3l (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of REV3L mRNA] CTD PMID:22206623 folic acid decreases expression ISO Rev3l (Mus musculus) 6480464 Folic Acid results in decreased expression of REV3L mRNA CTD PMID:25629700 formaldehyde increases expression ISO REV3L (Homo sapiens) 6480464 Formaldehyde results in increased expression of REV3L mRNA CTD PMID:20655997 and PMID:23649840 FR900359 affects phosphorylation ISO REV3L (Homo sapiens) 6480464 FR900359 affects the phosphorylation of REV3L protein CTD PMID:37730182 furan increases expression EXP 6480464 furan results in increased expression of REV3L mRNA CTD PMID:27387713 genistein decreases expression ISO REV3L (Homo sapiens) 6480464 Genistein results in decreased expression of REV3L mRNA CTD PMID:22228119 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of REV3L mRNA CTD PMID:33387578 indometacin multiple interactions ISO REV3L (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REV3L mRNA CTD PMID:28628672 lead(0) affects expression ISO REV3L (Homo sapiens) 6480464 Lead affects the expression of REV3L mRNA CTD PMID:28903495 melphalan decreases expression ISO REV3L (Homo sapiens) 6480464 Melphalan results in decreased expression of REV3L mRNA CTD PMID:22363485 mercury dibromide increases expression ISO REV3L (Homo sapiens) 6480464 mercuric bromide results in increased expression of REV3L mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO REV3L (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA CTD PMID:27188386 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of REV3L mRNA CTD PMID:30047161 methyl methanesulfonate increases expression ISO REV3L (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of REV3L mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO REV3L (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of REV3L mRNA CTD PMID:23179753 more ... miconazole decreases expression ISO Rev3l (Mus musculus) 6480464 Miconazole results in decreased expression of REV3L mRNA CTD PMID:27462272 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of REV3L mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO REV3L (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of REV3L mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO REV3L (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA CTD PMID:27188386 paracetamol decreases expression ISO REV3L (Homo sapiens) 6480464 Acetaminophen results in decreased expression of REV3L mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid decreases expression ISO REV3L (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of REV3L mRNA CTD PMID:27153767 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of REV3L mRNA CTD PMID:18158353 phenylmercury acetate increases expression ISO REV3L (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of REV3L mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO REV3L (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA CTD PMID:27188386 potassium chromate decreases expression ISO REV3L (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of REV3L mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO REV3L (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of REV3L mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of REV3L mRNA CTD PMID:30047161 progesterone multiple interactions ISO REV3L (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of REV3L mRNA CTD PMID:20660070 quercetin increases expression ISO REV3L (Homo sapiens) 6480464 Quercetin results in increased expression of REV3L mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO REV3L (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate increases expression ISO Rev3l (Mus musculus) 6480464 sodium arsenate results in increased expression of REV3L mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO REV3L (Homo sapiens) 6480464 sodium arsenite results in decreased expression of REV3L mRNA CTD PMID:12377979 sodium fluoride increases expression ISO Rev3l (Mus musculus) 6480464 Sodium Fluoride results in increased expression of REV3L mRNA CTD PMID:27862939 succimer multiple interactions ISO Rev3l (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of REV3L mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of REV3L mRNA CTD PMID:21641980 and PMID:26378955 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of REV3L mRNA CTD PMID:30047161 tamibarotene decreases expression ISO REV3L (Homo sapiens) 6480464 tamibarotene results in decreased expression of REV3L mRNA CTD PMID:15498508 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of REV3L mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of REV3L mRNA CTD PMID:25729387 trichostatin A increases expression ISO REV3L (Homo sapiens) 6480464 trichostatin A results in increased expression of REV3L mRNA CTD PMID:24935251 tungsten decreases expression ISO Rev3l (Mus musculus) 6480464 Tungsten results in decreased expression of REV3L mRNA CTD PMID:30912803 valproic acid increases methylation ISO REV3L (Homo sapiens) 6480464 Valproic Acid results in increased methylation of REV3L gene CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of REV3L mRNA CTD PMID:29427782 valproic acid increases expression ISO REV3L (Homo sapiens) 6480464 Valproic Acid results in increased expression of REV3L mRNA CTD PMID:28001369 vincaleukoblastine affects response to substance ISO REV3L (Homo sapiens) 6480464 REV3L protein affects the susceptibility to Vinblastine CTD PMID:16217747